Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma

OBJECTIVE: To describe the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinomas who are treated surgically and to analyze the occurrence of bladder tumors as well as the development of metastases outside the urinary tract. MATERIALS AND METHODS: The study comprised a retrospective analysis of 25 patients treated between February 1994 and August 2006. The variables analyzed were: patient age, gender, and clinical presentation; diagnostic methods; pathologic characteristics at the primary site of the tumor (pelvis or ureter); tumor stage and grade; and presence of carcinoma in situ, microvascular invasion and squamous differentiation. The Kaplan-Meier method and the Log-Rank test were used for statistical analysis of bladder recurrence-free survival. RESULTS: Eighty-four percent of patients were male, and macroscopic hematuria was the most common clinical presentation. The majority of cases (56%) were infiltrative (T2-T3) and high-grade (76%) tumors. Synchronous or metachronous bladder tumors were found in 72% of cases. Five (20%) patients had a history of bladder tumor before the diagnosis of upper urinary tract transitional cell carcinomas. The mean follow-up period was 36 months (range: 1.5 to 156). During the follow-up period, eleven (44%) patients developed bladder tumors. After five years, the probability of being free of bladder tumor recurrence was 40%. No pathological variable was predictive for bladder tumor recurrence. Four patients presented disease recurrence outside the urinary tract. CONCLUSIONS: The presence of metachronous bladder tumors is more often observed after the diagnosis of upper urinary tract transitional cell carcinomas. All of these patients should undergo rigorous follow-up during the postoperative period. Only patients with infiltrative and high-grade tumors developed metastases outside the urinary tract.

Saved in:
Bibliographic Details
Main Authors: Murta,Claudio B., Antunes,Alberto A., Dall'Oglio,Marcos F., Mosconi,Alcides, Leite,Kátia R., Srougi,Miguel
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2008
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322008000200011
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322008000200011
record_format ojs
spelling oai:scielo:S1807-593220080002000112008-04-18Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinomaMurta,Claudio B.Antunes,Alberto A.Dall'Oglio,Marcos F.Mosconi,AlcidesLeite,Kátia R.Srougi,Miguel Carcinoma Transitional cell/Urinary tract Prognosis Ureter Recurrence OBJECTIVE: To describe the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinomas who are treated surgically and to analyze the occurrence of bladder tumors as well as the development of metastases outside the urinary tract. MATERIALS AND METHODS: The study comprised a retrospective analysis of 25 patients treated between February 1994 and August 2006. The variables analyzed were: patient age, gender, and clinical presentation; diagnostic methods; pathologic characteristics at the primary site of the tumor (pelvis or ureter); tumor stage and grade; and presence of carcinoma in situ, microvascular invasion and squamous differentiation. The Kaplan-Meier method and the Log-Rank test were used for statistical analysis of bladder recurrence-free survival. RESULTS: Eighty-four percent of patients were male, and macroscopic hematuria was the most common clinical presentation. The majority of cases (56%) were infiltrative (T2-T3) and high-grade (76%) tumors. Synchronous or metachronous bladder tumors were found in 72% of cases. Five (20%) patients had a history of bladder tumor before the diagnosis of upper urinary tract transitional cell carcinomas. The mean follow-up period was 36 months (range: 1.5 to 156). During the follow-up period, eleven (44%) patients developed bladder tumors. After five years, the probability of being free of bladder tumor recurrence was 40%. No pathological variable was predictive for bladder tumor recurrence. Four patients presented disease recurrence outside the urinary tract. CONCLUSIONS: The presence of metachronous bladder tumors is more often observed after the diagnosis of upper urinary tract transitional cell carcinomas. All of these patients should undergo rigorous follow-up during the postoperative period. Only patients with infiltrative and high-grade tumors developed metastases outside the urinary tract.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.63 n.2 20082008-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322008000200011en10.1590/S1807-59322008000200011
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Murta,Claudio B.
Antunes,Alberto A.
Dall'Oglio,Marcos F.
Mosconi,Alcides
Leite,Kátia R.
Srougi,Miguel
spellingShingle Murta,Claudio B.
Antunes,Alberto A.
Dall'Oglio,Marcos F.
Mosconi,Alcides
Leite,Kátia R.
Srougi,Miguel
Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma
author_facet Murta,Claudio B.
Antunes,Alberto A.
Dall'Oglio,Marcos F.
Mosconi,Alcides
Leite,Kátia R.
Srougi,Miguel
author_sort Murta,Claudio B.
title Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma
title_short Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma
title_full Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma
title_fullStr Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma
title_full_unstemmed Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma
title_sort analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma
description OBJECTIVE: To describe the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinomas who are treated surgically and to analyze the occurrence of bladder tumors as well as the development of metastases outside the urinary tract. MATERIALS AND METHODS: The study comprised a retrospective analysis of 25 patients treated between February 1994 and August 2006. The variables analyzed were: patient age, gender, and clinical presentation; diagnostic methods; pathologic characteristics at the primary site of the tumor (pelvis or ureter); tumor stage and grade; and presence of carcinoma in situ, microvascular invasion and squamous differentiation. The Kaplan-Meier method and the Log-Rank test were used for statistical analysis of bladder recurrence-free survival. RESULTS: Eighty-four percent of patients were male, and macroscopic hematuria was the most common clinical presentation. The majority of cases (56%) were infiltrative (T2-T3) and high-grade (76%) tumors. Synchronous or metachronous bladder tumors were found in 72% of cases. Five (20%) patients had a history of bladder tumor before the diagnosis of upper urinary tract transitional cell carcinomas. The mean follow-up period was 36 months (range: 1.5 to 156). During the follow-up period, eleven (44%) patients developed bladder tumors. After five years, the probability of being free of bladder tumor recurrence was 40%. No pathological variable was predictive for bladder tumor recurrence. Four patients presented disease recurrence outside the urinary tract. CONCLUSIONS: The presence of metachronous bladder tumors is more often observed after the diagnosis of upper urinary tract transitional cell carcinomas. All of these patients should undergo rigorous follow-up during the postoperative period. Only patients with infiltrative and high-grade tumors developed metastases outside the urinary tract.
publisher Faculdade de Medicina / USP
publishDate 2008
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322008000200011
work_keys_str_mv AT murtaclaudiob analysisoftheclinicopathologicalcharacteristicsofpatientswithupperurinarytracttransitionalcellcarcinoma
AT antunesalbertoa analysisoftheclinicopathologicalcharacteristicsofpatientswithupperurinarytracttransitionalcellcarcinoma
AT dallogliomarcosf analysisoftheclinicopathologicalcharacteristicsofpatientswithupperurinarytracttransitionalcellcarcinoma
AT mosconialcides analysisoftheclinicopathologicalcharacteristicsofpatientswithupperurinarytracttransitionalcellcarcinoma
AT leitekatiar analysisoftheclinicopathologicalcharacteristicsofpatientswithupperurinarytracttransitionalcellcarcinoma
AT srougimiguel analysisoftheclinicopathologicalcharacteristicsofpatientswithupperurinarytracttransitionalcellcarcinoma
_version_ 1756432016855793664